Ax­some re­ports late-stage de­pres­sion tri­al de­feat, shares wilt

Months af­ter re­port­ing its ex­per­i­men­tal drug cleared a late-stage study in ma­jor de­pres­sive dis­or­der, Ax­some Ther­a­peu­tics un­veiled da­ta from a piv­otal study in treat­ment-re­sis­tant de­pres­sion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER